NAGE ev to operating cash flow history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Niagen Bioscience Inc EV to Operating Cash Flow — Quarterly
Period ending	EV to Operating Cash Flow
Jun 30, 2026	68.047×
Mar 31, 2026	-241.5921×
Dec 31, 2025	648.4402×
Sep 30, 2025	202.3489×
Jun 30, 2025	867.9585×
Mar 31, 2025	61.5183×
Dec 31, 2024	42.7264×
Sep 30, 2024	72.8189×
Jun 30, 2024	-676.6845×
Mar 31, 2024	838.6214×
Dec 31, 2023	123.7775×
Sep 30, 2023	219.0429×
Jun 30, 2023	28.1547×
Mar 31, 2023	34.2177×
Dec 31, 2022	-329.5215×
Sep 30, 2022	-20.156×
Jun 30, 2022	-26.5632×
Mar 31, 2022	-21.1058×
Dec 31, 2021	-46.9486×
Sep 30, 2021	-67.2892×
Jun 30, 2021	-80.4654×
Mar 31, 2021	-102.9174×
Dec 31, 2020	12,823.2364×
Sep 30, 2020	-60.8439×
Jun 30, 2020	-168.4984×
Mar 31, 2020	-35.0554×
Dec 31, 2019	-393.768×
Sep 30, 2019	-27.1257×
Jun 30, 2019	-26.219×
Mar 31, 2019	-70.5258×
Dec 31, 2018	-32.5624×
Sep 30, 2018	-37.0718×
Jun 30, 2018	-26.0645×
Mar 31, 2018	-44.0114×
Dec 31, 2017	-74.3571×
Sep 30, 2017	-376.6979×
Jun 30, 2017	-26.7567×
Mar 31, 2017	-1,995.2677×
Dec 31, 2016	650.7832×
Sep 30, 2016	-791.2249×
Jun 30, 2016	-1,646.2196×
Mar 31, 2016	-54.3908×
Dec 31, 2015	-154.9736×
Sep 30, 2015	-157.9394×
Jun 30, 2015	1,382.7177×
Mar 31, 2015	-237.3367×
Dec 31, 2014	-377.705×
Sep 30, 2014	-296.3797×
Jun 30, 2014	-252.7274×
Mar 31, 2014	-137.0892×
Dec 31, 2013	-89.3139×
Sep 30, 2013	-933.1822×
Jun 30, 2013	-57.5176×
Mar 31, 2013	-91.5883×
Dec 31, 2012	-64.9507×
Sep 30, 2012	-71.569×
Jun 30, 2012	-16.5277×
Mar 31, 2012	-11×
Dec 31, 2011	-26.1708×
Sep 30, 2011	-38.996×
Jun 30, 2011	-83.1381×
Mar 31, 2011	391.5004×
Dec 31, 2010	-86.9896×
Sep 30, 2010	-229.8984×
Jun 30, 2010	-39.4812×
Mar 31, 2010	81.3379×
Dec 31, 2009	91.9894×
Sep 30, 2009	-174.2443×
Jun 30, 2009	-25.5514×
Mar 31, 2009	-31.5987×
Dec 31, 2008	-142.1699×
Sep 30, 2008	-49.4237×
Jun 30, 2008	0×
Feb 29, 2008	0×
Nov 30, 2007	-17,155.6671×
Aug 31, 2007	-14,538.7997×
May 31, 2007	-3,477.432×
Feb 28, 2007	-4,480.3506×